Advanced Mesenchymal Enhanced Cell THerapY for SepTic Patients
Clinical trial NCT04961658 · TERMINATED
Trial details
- NCT number
- NCT04961658
- Sponsor
- Northern Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-11
- Primary completion
- 2023-08-10
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.